Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.
Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do ...
Read More: Ozempic and prescription weight loss drugs: How they work, what they cost, side effects, and everything to know The growing demand for GLP-1 drugs, which mimic hormones that ...
The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...
U.S. Health and Human Services Secretary Xavier Becerra says “this is a big deal.” Drug companies oppose the program.
There is a risk too many people are being diagnosed as obese when "a more accurate" and "nuanced" definition is needed, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback